OncoMed Pharmaceuticals, Inc.
     
 
 

Management

Paul J. Hastings
Chairman and Chief Executive Officer
John Lewicki, Ph.D.
Executive Vice President, Research and Development
Sunil Patel
Executive Vice President and Chief Financial Officer
Austin Gurney, Ph.D.
Chief Scientific Officer, Senior Vice President, Research
Alicia J. Hager, J.D., Ph.D.
Senior Vice President and General Counsel
Robert Stagg, Pharm.D.
Senior Vice President, Clinical Research and Development
Leonardo Faoro, MD, MBA
Vice President, Clinical Development
Jill Henrich
Vice President, Regulatory Affairs
Ann Kapoun, Ph.D.
Vice President, Translational Medicine
Stock Quote (NASDAQ: OMED)
Price:
3.90
Change:
- 0.17
Day High:
4.15
Day Low:
3.85
Volume:
159,756
1:21 PM ET on Dec 14, 2017
Delayed at least 20 minutes.
Provided by eSignal.
Search Investor Relations